AviadoBio annoncerede den 15. april, at den første deltager er blevet behandlet i deres fase 1/2 ASPIRE-FTD-forsøg, der evaluerer genterapien AVB-101 som en intervention for FTD-GRN. "Der er et kritisk behov for nye behandlinger for mennesker, der lever med FTD-GRN," sagde AviadoBios overlæge David Cooper, MD. "Manglen på effektive sygdomsmodificerende behandlinger ...

Not all forms of primary progressive aphasia (PPA) are caused by the same disease pathology with logopenic variant PPA (lvPPA) capable of being associated with either FTD or Alzheimer’s disease. This distinction was recently highlighted by the journey of lauded playwright Christopher Durang, who passed away from complications of lvPPA on April 2. Durang made…

In a recent interview with WTHI AFTD Ambassador Dawn Kirby recently shared her daughter’s FTD journey with WTHI-TV in Terre Haute, Ind., explaining how she turned her family’s pain into purpose by spreading awareness of the disease. While FTD is the most common dementia in people under 60, Kirby’s daughter Kara began to experience symptoms…